|
It appears that the FDA and Congress are trying to deal a final blow to GSK’s Avandia. The legislators have spent hundreds of hours reviewing tons of research and have decided that GSK withheld info about the potential for problems. (See Item #1.) To their credit GSK has decided to mount a strong defense. It seems to me that although this is important, I just can’t grasp why the two sides of the Senate can’t work this well together on healthcare reform.
Patients are starting to use Victoza and now that the drug is starting to get exposure in non-controlled situations it will be interesting to see what the results are. Speaking of GLP-1 mimetics, the bad weather in DC has held up review of the Amylin’s once a week version of Byetta. It seems that all the snow last week shut down the FDA for 5 days and so the PDUFA of this new compound has been postponed till March 12th due to weather.
Michelle Obama has taken it upon herself to ramp up the campaign to stamp out childhood obesity. Our physical activity guru, Sheri Colberg, Ph.D., FACSM, decided to go at it from a professional standpoint and wants you to read Get Your Kids Moving, Too, and then print it out to hand to every parent you know.
Announcements:
Taking Control of Your Diabetes (TCOYD): Kalispell, Montana, March 20
The TCOYD team will be in Kalispell, Montana, at the Hilton Garden Inn for the TCOYD Conference and Health Fair, March 20. TCOYD is a not for profit organization dedicated to informing and empowering people with diabetes to become actively involved in their own health care. For more 2010 upcoming conference details, please go to TCOYD.org.
dLife.com: February 28, 7PM ET on CNBC
In this “Best of dLife” special, dLife revisits those people with diabetes who have inspired us the most by their achievements and attitudes. From a 96-year-old pole vaulter to a prima ballerina, catch up with audience favorites. Make the most of your dLife and don't miss an episode: Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.
New Poll!
Please answer this week's poll question (in the column to the right):
Will you recommend Byetta LAR if it is approved?
*****************************
We can make a difference!
*****************************
Check out this week's "Test Your Diabetes Knowledge" question!
Dave Joffe, Editor-in-chief
|
Entries (RSS News)
